Transformation of non-cancerous human breast epithelial cell line MCF10A by the tobacco-specific carcinogen NNK

Breast Cancer Research and Treatment

Volumn 79, Issue 1, 2003, Pages 95-105

  Mei, Jianxun ^a   Hu, Hongbo ^a   McEntee, Michael ^a   Plummer III, Howard ^a   Song, Ping ^a   Wang, Hwa Chain R ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Human breast cancer; Human breast epithelial cells; MCF10A; NNK; Tobacco specific carcinogen; Tumor

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; CARCINOGEN; ESTRADIOL; MITOGEN ACTIVATED PROTEIN KINASE;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST EPITHELIUM; CELL FUNCTION; CELL MOTILITY; CELL PROLIFERATION; DOWN REGULATION; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; BREAST; CARCINOGENICITY TESTS; CARCINOGENS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; ESTRADIOL; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NITROSAMINES; TOXICITY TESTS, CHRONIC;

EID: 0037689101     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023326121951     Document Type: Article

References (36)

1. Hecht SS: Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91: 1194-1210, 1999
2. Hecht SS: Recent studies on mechanisms of bioactivation and detoxification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco, specifc lung carcinogen. Crit Rev Toxicol 26: 163-181, 1996
3. Jee SH, Ohrr H, Kim IS: Effects of husbands' smoking on the incidence of lung cancer in Korean women. Int J Epidemiol 28: 824-828, 1999
4. Lash TL, Aschengrau A: Active and passive cigarette smoking and the occurrence of breast cancer. Am J Epidemiol 149: 5-12, 1999
5. Morabia A: Smoking (active and passive) and breast cancer: epidemiologic evidence up to June 2001. Env Mol Mutagenesis 39: 89-95, 2002
6. Hecht SS: Tobacco smoke carcinogens and breast cancer. Env Mol Mutagenesis 39: 119-126, 2002
7. Perera FP, Estabrook A, Hewer A, Channing K, Rundle A, Mooney LA, Whyatt R, Phillips DH: Carcinogen, DNA adducts in human breast tissue. Cancer Epidemiol Biomarkers Prev 4: 233-238, 1995
8. Wu Z, Upadhyaya P, Carmella SG, Hecht SS, Zimmerman CL: Disposition of 4-(methylnitrosamino)-1-(3-pyfidyl)-1-butanone (NNK) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in bile duct-cannulated rats: stereoselective metabolism and tissue distribution. Carcinogenesis 23: 171-179, 2002
9. Schuller HM, Orloff M: Tobacco-specific carcinogenic nitrosamines: ligands for nicotinic acetylcholine receptors in human lung cancer cells. Biochem Pharmacol 55: 1377-1384, 1998
10. Schuller HM, Tithof PK, Williams M, Plummer III H: The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a beta-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via beta adrenergicreceptor-mediated release of arachidonic acid. Cancer Res 15(59): 4510-4515, 1999
11. Schuller HM, Porter B, Riechert A: Beta-adrenergic modulation of NNK-induced lung carcinogenesis in hamsters. J Cancer Res Clin Oncol 126: 624-630, 2000
12. Schuller HM, Jull BA, Sheppard BJ, Plummer III H: Interaction of tobacco-specific toxicants with the neuronal alpha(7) nicotinic acetylcholine receptor and its associated mitogenic signal transduction pathway: potential role in lung carcinogenesis and pediatric lung disorders. Eur J Pharmacol 393: 265-277, 2000
13. Jull BA, Plummer III HK, Schuller HM: Nicotinic receptor-mediated activation by the tobacco-specific nitrosamine NNK of a Raf-1/MAP kinase pathway, resulting in phosphorylation of c-myc in human small cell lung carcinoma cells and pulmonary neuroendocrine cells. J Cancer Res Clin Oncol 127: 707-717, 2001
14. Sabourin CL, Wang QS, Ralston SL, Evans J, Coate J, Herzog CR, Jones SL, Weghorst CM, Kelloff GJ, Lubet RA, You M, Stoner GD: Expression of cell cycle proteins in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumors. Exp Lung Res 24: 499-521, 1998
15. Soule HD, Maloney TM, Wolman SR, Peterson Jr WD, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF, Brooks SC: Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50: 6075-6086, 1990
16. Hecht SS, Trushin N, Reid-Quinn CA, Burak ES, Jones AB, Southers JL, Gombar CT, Carmella SG, Anderson LM, Rice JM: Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butane in the patas monkey; pharmacokinetics and characterization of glucuronide metabolites. Carcinogenesis 14: 229-236, 1993
17. H. Cancer Res 50: 67-71, 1990
18. 3H]-thymidine uptake by stimulated human lymphocytes. Cell Tissue Kinet 13: 21-32, 1980
19. Song MK, Krutzsch H, Hankins WD, Richards W-L, Thorgeirsson SS: Rapid determination of DNA synthesis in adherent cells grown in microtiter plates. Exp Cell Res 156: 271-276, 1985
20. Wang HCR, Fecteau KA: Detection of a novel quiescence-dependent protein kinase. J Biol Chem 275: 25850-25857, 2000
21. Fecteau KA, Mei J, Wang HCR: Differential modulation of signaling pathways and apoptosis of ras-transformed 10T1/2 cells by the depsipeptide FR901228. J Pharmacol Exp Ther 300: 890-899, 2002
22. Kahn D, Andrieu JM, Dray F: Evaluation of some binding characteristics using dextran-coated charcoal to separate the bound and flee fractions. Immunochemistry 11: 327-332, 1974
23. Schata F, Gurpide E: Effects of estradiol on prostaglandin F2α levels in primary monolayer cultures of epithelial cells from human proliferative endometrium. Endocrinol 113: 1274-1279, 1983
24. Jeffrey JJ, Ehlich LS, Roswit WT: Serotonin: an inducer of collagenase in myometrial smooth muscle cells. J Cell Physiol 146: 399-406, 1991
25. Repesh LA: A new in vitro assay for quantitating tumor cell invasion. Invasion Metastasis 9: 192-208, 1989
26. Sun XG, Rotenberg SA: Overexpression of protein kinase Cα in MCF-10A human breast cells engenders dramatic alterations in morphology, proliferation, and motility. Cell Grow Diff 10: 343-352, 1999
27. Nollet F, Berx G, van Roy F: The role of the E-cadherin/catenin adhesion complex in the development and progression of cancer. Mol Cell Biol Res Commun 2: 77-85, 1999
28. Critchley DR: Focal adhesions - the cytoskeletal connection. Curr Opin Cell Biol 12: 133-139, 2000
29. Campbell SL, Khosravi-Far R, Rossman KL, Clark GL, Der CJ: Increased complexity of Ras signaling. Oncogene 17: 1395-1413, 1998
30. Wang HCR, Erikson RL: Activation of protein serine/threonine kinases p42, p63 and 87 in Rous sarcoma virus-transformed cells: signal transduction/transformation-dependent MBP kinases. Mol Biol Cell 3: 1329-1337, 1992
31. Mehta RR, Graves JM, Hart GD, Shilkaitis A, Das Gupta TK: Growth and metastasis of human breast carcinomas with Matrigel in athymic mice. Breast Cancer Res Treat 25: 65-71, 1993
32. Mullen P, Ritchie A, Langdon SP, Miller WR: Effect of Matrigel on the tumorigenicity of human breast and ovarian carcinoma cell lines. Int J Cancer 67: 816-820, 1996
33. Clark GJ, Kinch MS, Gilmer TM, Burridge K, Der CJ: Overexpression of the Ras-related TC21/R-Ras2 protein may contribute to the development of human breast cancers. Oncogene 12: 169-176, 1995
34. Freedman VH, Shin SI: Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell 3: 355-359, 1974
35. Basolo F, Elliott J, Tait L, Chen XQ, Maloney T, Russo IH, Pauley R, Momiki S, Caamano J, Klein-Szanto AJP, Koszalka M, Russo J: Transformation of human breast epithelial cells by c-Ha-ras oncogene. Mol Carcinog 4: 25-35, 1991
36. English J, Pearson G, Wilsbacher J, Swantek J, Karandikar M, Xu S, Cobb MH: New insights into the control of MAP kinase pathways. Exp Cell Res 253: 255-270, 1999